Literature DB >> 11678971

Diabetes control deteriorates in girls at cessation of growth: relationship with body mass index.

K Tylleskär1, T Tuvemo, J Gustafsson.   

Abstract

AIM: Diabetic patients, particularly girls, often experience poor metabolic control during puberty and adolescence. The aim of this study was to investigate metabolic control during adolescence, especially in relation to pubertal stages, growth, insulin treatment and body mass index (BMI).
METHODS: We studied the records of 38 (consecutive) girls with prepubertal onset of Type 1 diabetes mellitus. Data from the age of 10 to 18-20 years were obtained with regard to glycaemic control, growth, age at menarche, final height and BMI, and analysed in relation to both chronological age and age at menarche.
RESULTS: HbA1c was lowest 3 years before menarche; mean (+/- sd) 7.6 (+/- 1.2). After the pubertal growth spurt, there was a marked impairment of metabolic control, the highest level of HbA1c occurring 3 years after menarche. Mean age at menarche was 13.3 (+/- 1.1) years and mean linear growth after menarche only 4.7 cm, giving a final height of 164.9 (+/- 5.3) cm which is 2.7 cm below the Swedish mean. During adolescence the degree of correlation between BMI and HbA1c continuously increased, pointing out the effect of body fat on metabolic control in this age group. The level of HbA1c at 10 years of age could not predict the metabolic control after cessation of puberty, but prepubertal BMI appears to be a risk factor for both obesity and poor glycaemic control in late adolescence.
CONCLUSIONS: The highest HbA1c was found after cessation of growth. Prepubertal BMI is a possible predictor of metabolic control in adolescent diabetic girls.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11678971     DOI: 10.1046/j.1464-5491.2001.00587.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes.

Authors:  Kirstie K Danielson; Mari Palta; Catherine Allen; Donn J D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2005-10-04       Impact factor: 5.958

2.  Sociodemographic determinants of glycaemic control among children with type 1 diabetes in South Eastern Nigeria.

Authors:  Chinwe Flora Ogugua; Ugo Nnenna Chikani; Chikosolu Yvonne Okiche; Ugochi Maryann Ibekwe
Journal:  Pan Afr Med J       Date:  2021-03-09

3.  Bone Density, Geometry, and Mass by Peripheral Quantitative Computed Tomography and Bone Turnover Markers in Children with Diabetes Mellitus Type 1.

Authors:  Maciej Jaworski; Elżbieta Wierzbicka; Edyta Czekuć-Kryśkiewicz; Paweł Płudowski; Maria Kobylińska; Mieczysaw Szalecki
Journal:  J Diabetes Res       Date:  2022-04-18       Impact factor: 4.061

4.  Good glycemic control without exceeding the BMI trajectory during the first 5 years of treatment in children and adolescents with type 1 diabetes.

Authors:  Annika Grönberg; Per-Ola Carlsson
Journal:  Pediatr Diabetes       Date:  2022-01-19       Impact factor: 3.409

5.  Bone Mineral Density and Type 1 Diabetes in Children and Adolescents: A Meta-analysis.

Authors:  Phoebe Loxton; Kruthika Narayan; Craig F Munns; Maria E Craig
Journal:  Diabetes Care       Date:  2021-07-20       Impact factor: 17.152

6.  Glycemic Control in Kenyan Children and Adolescents with Type 1 Diabetes Mellitus.

Authors:  Thomas Ngwiri; Fred Were; Barbara Predieri; Paul Ngugi; Lorenzo Iughetti
Journal:  Int J Endocrinol       Date:  2015-10-01       Impact factor: 3.257

7.  Body fat measurement in adolescent girls with type 1 diabetes: a comparison of skinfold equations against dual-energy X-ray absorptiometry.

Authors:  S Särnblad; A Magnuson; U Ekelund; J Åman
Journal:  Acta Paediatr       Date:  2016-04-06       Impact factor: 2.299

8.  Recovery of premorbid BMI trajectory without overshoot during the first year of treatment of children with type 1 diabetes.

Authors:  Annika Grönberg; Ingemar Swenne
Journal:  BMJ Open Diabetes Res Care       Date:  2016-07-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.